Related Experiment Video
Updated: Jul 8, 2026

Spectral Confocal Imaging of Fluorescently tagged Nicotinic Receptors in Knock-in Mice with Chronic Nicotine Administration
Published on: February 10, 2012
Nicotine and addiction. The Brown and Williamson documents
1Department of Medicine, St Peter's Medical Center, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, New Brunswick, USA.
Tobacco companies Brown and Williamson (B&W) and British American Tobacco (BAT) consistently viewed nicotine as key to tobacco use and addiction between 1962-1984. Their research focused on nicotine
Area of Science:
- Pharmacology
- Tobacco Industry Research
- Nicotine Science
Background:
- Historical tobacco industry documents provide insight into corporate perspectives.
- Understanding past industry views on nicotine is crucial for public health.
Purpose of the Study:
- To analyze how major tobacco companies, specifically Brown and Williamson (B&W) and British American Tobacco (BAT), perceived and researched nicotine.
- To examine internal tobacco company documents regarding nicotine's role in tobacco use.
Main Methods:
- Analysis of confidential reports, internal memoranda, and research documents from B&W and BAT.
- Review of materials spanning 22 years (1962-1984).
Main Results:
- B&W and BAT consistently identified nicotine as the primary pharmacological agent responsible for tobacco use.
- Internal documents explicitly addressed nicotine addiction early in the study period.
- Company research focused on nicotine's pharmacological effects, not taste or flavor.
- Evidence suggests an intent to manipulate bodily functions using nicotine.
Conclusions:
- Tobacco companies recognized nicotine's central role in addiction and product function.
- Research and internal communications centered on nicotine's pharmacological impact.
- The industry's focus was on the physiological effects of nicotine, not sensory attributes.
Related Concept Videos
Drug Dependence
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Drug Abuse and Addiction: Pharmacological Phenomena
CNS Depressants: Alcohol and Nicotine
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...

